CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −41,847 | $230.03 | $9.6M | 164,702 |
| 2026-02-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −20,079 | $230.95 | $4.6M | 144,623 |
| 2026-02-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −9,197 | $232.41 | $2.1M | 135,426 |
| 2026-02-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −7,445 | $233.31 | $1.7M | 127,981 |
| 2026-02-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −100 | $234.00 | $23K | 127,881 |
| 2026-01-30 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Grant or award 10b5-1 | +6,135 | 181,675 | ||
| 2026-01-30 | Chapman Rowan E Director | Grant or award | +97 | 5,874 | ||
| 2026-01-30 | Bertagnolli Monica Director | Grant or award | +70 | 5,291 | ||
| 2026-01-30 | Marcus Gail Boxer Director | Grant or award | +91 | 5,853 | ||
| 2026-01-30 | Baynes Roy D. Director | Grant or award | +70 | 18,429 | ||
| 2026-01-30 | Williams Brinkley Ruth Director | Grant or award | +73 | 5,389 | ||
| 2026-01-30 | ROSENMAN HERM Director | Grant or award | +99 | 20,441 | ||
| 2026-01-30 | BOTHA ROELOF Director | Grant or award | +112 | 2,540 | ||
| 2026-01-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −991 | $229.94 | $228K | 59,935 |
| 2026-01-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −876 | $230.92 | $202K | 59,059 |
| 2026-01-28 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −928 | $237.66 | $221K | 175,540 |
| 2026-01-28 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,200 | $237.66 | $285K | 142,486 |
| 2026-01-28 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,000 | $237.66 | $238K | 225,147 |
| 2026-01-28 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −3,648 | $237.66 | $867K | 213,180 |
| 2026-01-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,237 | $237.66 | $294K | 62,102 |
Page 27 of 39 · 767 trades